Monitoring NTI drugs involves frequent blood tests to measure drug levels, observing for signs and symptoms of toxicity, and assessing therapeutic effects. For example, patients on warfarin require regular INR (International Normalized Ratio) checks to ensure their blood is not too thin or too thick. Digoxin levels must be monitored to prevent cardiac toxicity, while lithium levels are checked to avoid neurotoxicity.
